Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

231.04 +1.49 (+0.65%)
Streaming Delayed Price Updated: 12:15 PM EST, Jan 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Innovative Water Tech Stocks to Watch in a Thirsty World
The world is in need of water scarcity solutions. These water tech stocks are doing their part while offering upside potential for investors. 
Via InvestorPlace
7 Healthcare Stocks With Huge Return Potential for Long-Term Investors
These leading healthcare companies have proven that they can deliver reliable gains to their shareholders over many years and decades. 
Via InvestorPlace
Analyst Ratings for Danaher
Via Benzinga
Credit Suisse Maintains Neutral Rating for Danaher: Here's What You Need To Know
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023
Via Benzinga
Danaher Earnings Perspective: Return On Capital Employed
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Why Catalent Stock Tumbled by Nearly 6% on Tuesday
A warning about revenue and the abandonment of a potential suitor are recent developments that continue to hammer sentiment on the company. 
Via The Motley Fool
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Danaher Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Why Danaher Shares Are Falling Today
Via Benzinga
Looking At Danaher's Recent Unusual Options Activity
Via Benzinga
Here's How Much $100 Invested In Danaher 5 Years Ago Would Be Worth Today
Via Benzinga
Why Catalent Shares Are Falling Today
Via Benzinga
These 2 Large-Cap Laggards Are Leading Markets Lower Tuesday
Investors worry that an economic recession could hit entire swaths of the stock market hard. 
Via The Motley Fool
3 Healthcare Stocks With Huge Growth Potential
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Catalent Stock Dove More Than 7% Today
The specialty healthcare company is having a miserable couple of days on the exchange. 
Via The Motley Fool
7 Stocks That Hedge Funds Are Dumping Now
Everyone loves talking about what institutional players are buying. On the flipside, here’s a list of hedge fund stocks to avoid. 
Via InvestorPlace
Why Catalent Stock Slumped on Monday
It looks like the company won't be acquired after all...at least for now. 
Via The Motley Fool
What 5 Analyst Ratings Have To Say About Danaher
Via Benzinga
$100 Invested In Danaher 5 Years Ago Would Be Worth This Much Today
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Via Benzinga
3 Stocks to Buy for Life-Changing Wealth Potential
Investors hoping to succeed in the stock market should consider taking a position in these leading companies, each of which has outperformed. 
Via InvestorPlace
Etsy To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday
B of A Securities cut the price target for Stem, Inc. (NYSE: STEM) from $9 to $5. B of A Securities analyst Julien Dumoulin-Smith downgraded the stock from Neutral to Underperform. Stem shares fell... 
Via Benzinga
Looking At Danaher's Recent Unusual Options Activity
Via Benzinga
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
These companies strive to bring down the cost of developing new therapies. 
Via The Motley Fool
Eli Lilly Stock Shows Improved Relative Price Performance; Still Shy Of Benchmark
On Tuesday, Eli Lilly stock got an upgrade to its Relative Strength (RS) Rating, to 74 from 68 a day earlier. 
Via Investor's Business Daily
This Year’s 5 Top InvestorPlace.com Stock Pickers
If you are looking for stocks to buy, the top InvestorPlace.com stock pickers have demonstrated their skills so far in 2023. 
Via InvestorPlace
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.